EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease

Amalia Di Petrillo iD, Antonella Fais, Nicola Raho, Benedetta Era, Faustina Barbara Cannea, Alessandra Padiglia, Eleonora Grecu, Daniela Murtas, Cristina Maxia, Valeria Sogos, Clara Porcedda, Pierluigi Caboni und 4 weitere

Inflammatory Bowel Diseases · 01.12.2025 · 31 (12) · 3398-3406

DOI: 10.1093/ibd/izaf231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 22.10.2025. Verfasst von Amalia Di Petrillo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science and Public Health, University of Cagliari, Monserrato, Italy. Hauptthemen laut MEDLINE: Xanthine Oxidase, Colitis, Ulcerative, Crohn Disease, Allopurinol. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione di Sardegna, CUP, Fondazione di Sardegna: project title "Xanthine Oxidase.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance and Objective Xanthine oxidase (XO) plays a key role in purine metabolism, catalyzing the oxidation of hypoxanthine to xanthine, and xanthine to uric acid (UA) with the production of superoxide anions. The accumulation of UA has been shown to initiate the inflammatory process through NLRP3 inflammasome, and the production of reactive oxygen species (ROS) contributes to inflammation-related tissue damage in different organs. This study aimed to investigate the role of XO in the pathogenesis of Inflammatory Bowel Disease (IBD) and the anti-inflammatory potential of XO inhibition.

Design

XO expression and activity were assessed in the mucosa of moderately-to-severely active ulcerative colitis (UC) and Crohn’s disease (CD) patients. The functional role of XO, the activation of NLRP3 inflammasome, and the expression of proinflammatory cytokines were investigated in ex vivo intestinal organ cultures in the presence or absence of XO inhibitors.

Results

In silico and in vitro analysis showed that XO mRNA and protein expression were upregulated in the UC and CD intestinal mucosa compared to controls. XO overexpression in the inflamed mucosa was associated with increased enzymatic activity, accumulation of UA and functionally linked to NLRP3-dependent IL1beta and IL18 expression. Accordingly, XO inhibitors, Allopurinol and Febuxostat, prevented NLRP3 activation, reduced Caspase1 activity and IL1beta and IL18 expression in ex vivo organ cultures of inflamed intestinal mucosa from both UC and CD patients. Conclusions and Relevance Overexpression of XO in IBD might contribute to inflammation by promoting NLRP3 inflammasome activation and proinflammatory cytokine production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xanthine OxidaseColitis, UlcerativeCrohn DiseaseAllopurinolNLR Family, Pyrin Domain-Containing 3 ProteinUric AcidInflammationRNA, MessengerHumansMaleFemaleAdultIntestinal Mucosa

Stichwörter der Autor:innen

inflammasomeinflammatory bowel diseasexanthine oxidase

Substanzen

Xanthine OxidaseNLR Family, Pyrin Domain-Containing 3 ProteinUric AcidRNA, MessengerAllopurinol

Autor:innen und Institutionen

  • Department of Medical Science and Public Health, University of Cagliari, Monserrato, Italy.
  • Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy.
  • Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
  • Azienda Ospedaliero-Universitaria di Cagliari, Monserrato, Italy.

ORCID-Profile: Amalia Di Petrillo, Sara Onali, Massimo Claudio Fantini

Förderung

  • Fondazione di Sardegna
  • CUP
  • Fondazione di Sardegna: project title "Xanthine Oxidase
  • Inflammatory Bowel Disease
  • Fondazione di Sardegna: project title “Xanthine Oxidase

Zitieren

APA

Di Petrillo, A., Fais, A., Raho, N., Era, B., Cannea, F. B., Padiglia, A., Grecu, E., Murtas, D., Maxia, C., Sogos, V., Porcedda, C., Caboni, P., Demurtas, M., Favale, A., Onali, S., & Fantini, M. C. (2025). Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 31(12), 3398-3406. https://doi.org/10.1093/ibd/izaf231

Vancouver

Di Petrillo A, Fais A, Raho N, Era B, Cannea FB, Padiglia A, et al. Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2025;31(12):3398-3406. doi:10.1093/ibd/izaf231

BibTeX
@article{DiPetrillo2025,
  author = {Di Petrillo, Amalia and Fais, Antonella and Raho, Nicola and Era, Benedetta and Cannea, Faustina Barbara and Padiglia, Alessandra and Grecu, Eleonora and Murtas, Daniela and Maxia, Cristina and Sogos, Valeria and Porcedda, Clara and Caboni, Pierluigi and Demurtas, Mauro and Favale, Agnese and Onali, Sara and Fantini, Massimo Claudio},
  title = {Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  volume = {31},
  number = {12},
  pages = {3398--3406},
  doi = {10.1093/ibd/izaf231}
}
Kostenlos starten →